期刊文献+

应用腰痛方治疗腰椎间盘突出症的临床研究 被引量:3

Clinical Efficacy of Lumbago Decoction in Treating Lumbar Disc Herniation
在线阅读 下载PDF
导出
摘要 目的观察陈宝田教授经验方腰痛方治疗腰椎间盘突出症(LDH)的临床疗效,初步分析中药治疗LDH的优势。方法将60例符合纳入标准的患者随机分为两组,治疗组30例采用陈宝田教授腰痛方治疗,对照组30例采用西乐葆治疗,疗程28 d,比较两组总体疗效及症候积分。结果两组之间的总体有效率相比较,差异具有统计学意义(P<0.05),其中,治疗组的总体疗效优于对照组;治疗组在治疗14 d,整体疗效优于西乐葆组,在治疗28 d后,在升高症候总积分及改善腰痛、腿痛及感觉障碍等主要临床症状和体征方面的疗效明显优于对照组(P<0.05)。结论陈宝田教授腰痛方治疗LDH的疗效优于西乐葆,值得推广应用。 Objective To observe the clinical efficacy of Lumbago decoction,the experienced prescription of Professor Chen Bao-tian,in treating lumbar disc herniation(LDH) and in order to preliminarily analyze the advantage of traditional Chinese medicine in treating LDH.Methods A total of 60 patients with LDH who met the inclusion criteria were randomly divided into treatment group(n=30) and control group(n=30).The Lumbago decoction was orally given in the treatment group,while Celebrex was given in the control group;the course of treatment was 28 days.The two groups were compared in term of overall response rate and main symptom scores.Results Within these two groups,there was a significant difference in response rate(P〈0.05),the response of treatment group was better than control group.After treated for 14 days,the total symptoms score of treatment group was better than control group(P〈0.05).After treated for 28 days,the total symptoms score,release of low back pain and release of leg pain in treatment group was better than in control group(P〈0.05).Conclusion Lumbago decoction has a better clinical effect compared with Celebrex in the treatment of LDH and is superior to meloxicam in benefit symptom scores.This prescription shows promise for clinical application.
出处 《中国医药指南》 2016年第14期28-30,共3页 Guide of China Medicine
关键词 腰椎间盘突出症 陈宝田 经验方 腰痛方 Lumbar disc herniation CHEN Baotian Experienced Prescription Lumbago decoction
  • 相关文献

参考文献4

二级参考文献30

  • 1蒋宗滨.非甾体抗炎药不良反应的临床研究[J].中国疼痛医学杂志,2006,12(4):241-243. 被引量:36
  • 2Clays E, De Bacquer D, Leynen F, et al. The impact ofpsychosocial factors on low back pain: longitudinal results from the Belstress study[J]. Spine, 2007, 32(2): 262-8.
  • 3Shift R, Karppinen J, Leino-Arjas P, et al. Cardiovascular and lifestyle risk factors in lumbar radicular pain or clinically defined sciatica: a systematic review [J]. Spine J, 2007, 16(12): 2043-54.
  • 4Battie MC, Videman T, Levalahti E, et al. Heritability of low back pain and the role of disc degeneration[ J ]. Pain, 2007, 131(3): 272-80.
  • 5Battie MC, Videman T. Lumbar disc degeneration: epidemiology and genetics [J]. J Bone Joint Surg Am, 2006, 88(Suppl 2): 3-9.
  • 6Varlotta GP, Brown MD, Kelsey JL, et al. Familial predisposition for herniation of a lumbar disc in patients who are less than twenty-one years old[J ]. J Bone Joint Surg Am, 1991, 73 (1): 124-8.
  • 7Matsui H, Terahata N, Tsuji H, et al. Familial predisposition and clustering for juvenile lumbar disc herniation [ J ]. Spine, 1992, 17 (11): 1323-7.
  • 8Simmons ED Jr, Guntupalli M, Kowalski JM, et al. Familial predisposition for degenerative disc disease. A case-control study [J]. Spine, 1996, 21(13): 1527-9.
  • 9Matsui H, Kanamori M, Ishihara H, et al. Familial predisposition for lumbar degenerative disc disease. A case-control study [J]. Spine, 1998, 23(9): 1029-34.
  • 10Cheung KM, Chan D, Karppinen J, et al. Association of the Taq I allele in vitamin D receptor with degenerative disc disease and disc bulge in a Chinese population[J]. Spine, 2006, 31(10): 1143-8.

共引文献51

同被引文献31

引证文献3

二级引证文献5

相关作者

内容加载中请稍等...

相关机构

内容加载中请稍等...

相关主题

内容加载中请稍等...

浏览历史

内容加载中请稍等...
;
使用帮助 返回顶部